Figure 2. Effect of silymarin on the serum level of glucose (mg/dl), insulin (, blood HBA1c % and HOMA-IR % of experimental groups. All values are expressed as mean ±SD. Each group consists of six albino rats. *P < 0.05 with respect to control group. # P < 0.05 with respect to diabetic group


Silymarin ameliorates Metabolic Risk Factors and Protects against Cardiac Apoptosis in Streptozotocin-induced Diabetic Rats

Monera A Alabdan

Biomedicine and Biotechnology. 2015, 3(2), 20-27 doi:10.12691/bb-3-2-1